Quantum BioPharma (NASDAQ: QNTM) , a biopharmaceutical company focused on innovative biotech assets, announced a non-brokered private placement of cl ...

Quantum BioPharma (NASDAQ: QNTM) a biopharma company focused on biotech innovation, announced that portfolio company Unbuzzd Wellness Inc. has partn ...

Quantum BioPharma retains ownership of 25.71% (as of June 30, 2024) of Celly Nutrition www.unbuzzd.com. The agreement with Celly Nutrition also includes royalty payments of 7% of sales from unbuzzd™ ...

Individual results may vary. unbuzzd™ is a dietary supplement. Consuming unbuzzd™ after alcohol ingestion does not permit you to operate a vehicle. Drink responsibly. DO NOT DRINK AND DRIVE.

Quantum BioPharma retains ownership of 25.71% (as of June 30, 2024) of Celly Nutrition www.unbuzzd.com. The agreement with Celly Nutrition also includes royalty payments of 7% of sales from unbuzzd™ ...

FSD Pharma and Celly announced the imminent launch of its product, unbuzzd, which is expected to launch as a mixable in three packs and eighteen packs on Amazon later this month.

FSD Pharma has also licensed unbuzzd™, a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of quickly relieving ...